Cardlytics (CDLX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Preliminary proxy statement filed for upcoming shareholder meeting, outlining key proposals and governance matters.
Voting matters and shareholder proposals
Shareholders will be asked to vote on proposals detailed in the preliminary proxy statement.
Board of directors and corporate governance
Proxy statement identifies the registrant and specifies the filing is made by the registrant.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Cardlytics
- Revenue and billings fell, but operational gains and U.K. growth support optimism for 2026.CDLX
Q4 20254 Mar 2026 - Revenue down 9% but net loss narrowed as platform modernization and transformation continue.CDLXQ2 20242 Feb 2026
- Q3 revenue fell 15% to $67.1M, with a $145M net loss from impairment charges.CDLXQ3 202416 Jan 2026
- Q4 beat guidance despite a 10% revenue drop; 2025 targets sequential gains and profitability.CDLXQ4 202424 Dec 2025
- Proxy covers director elections, auditor ratification, new equity plan, and executive pay reforms.CDLXProxy Filing1 Dec 2025
- Proxy update adds XBRL tagging and details strict insider trading and equity award policies.CDLXProxy Filing1 Dec 2025
- Revenue dropped 8.4% but net loss narrowed as user base grew and cost controls took effect.CDLXQ1 202526 Nov 2025
- Q2 revenue fell 9% as billings and net loss worsened; Q3 billings to drop 15%-22%.CDLXQ2 202523 Nov 2025
- Revenue and billings dropped, but net loss narrowed and user growth remained strong.CDLXQ3 202513 Nov 2025